X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Sterling Biotech with VENUS REMEDIES - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

STERLING BIOTECH vs VENUS REMEDIES - Comparison Results

STERLING BIOTECH    Change

Sterling Biotech primarily produces and distributes pharmaceutical grade gelatine globally. The company currently has a 7.5% share of the global market for pharmaceutical and nutraceutical gelatines. It has more than 70% market share in India. Sterli... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    STERLING BIOTECH VENUS REMEDIES STERLING BIOTECH/
VENUS REMEDIES
 
P/E (TTM) x -1.6 -672.5 - View Chart
P/BV x 0.1 0.2 32.3% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 STERLING BIOTECH   VENUS REMEDIES
EQUITY SHARE DATA
    STERLING BIOTECH
Dec-13
VENUS REMEDIES
Mar-16
STERLING BIOTECH/
VENUS REMEDIES
5-Yr Chart
Click to enlarge
High Rs11218 4.8%   
Low Rs382 4.1%   
Sales per share (Unadj.) Rs26.8365.6 7.3%  
Earnings per share (Unadj.) Rs-15.01.5 -1,006.5%  
Cash flow per share (Unadj.) Rs-5.537.9 -14.4%  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs54.9382.5 14.3%  
Shares outstanding (eoy) m267.8711.44 2,341.5%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.30.4 63.2%   
Avg P/E ratio x-0.5101.0 -0.5%  
P/CF ratio (eoy) x-1.34.0 -32.2%  
Price / Book Value ratio x0.10.4 32.3%  
Dividend payout %00-   
Avg Mkt Cap Rs m1,8621,717 108.5%   
No. of employees `0001.41.0 132.7%   
Total wages/salary Rs m547324 168.6%   
Avg. sales/employee Rs Th5,303.34,100.7 129.3%   
Avg. wages/employee Rs Th403.8318.0 127.0%   
Avg. net profit/employee Rs Th-2,959.016.7 -17,754.1%   
INCOME DATA
Net Sales Rs m7,1814,183 171.7%  
Other income Rs m4320 211.9%   
Total revenues Rs m7,2234,203 171.9%   
Gross profit Rs m947812 116.7%  
Depreciation Rs m2,543417 610.2%   
Interest Rs m4,377380 1,152.5%   
Profit before tax Rs m-5,93135 -16,896.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-1,92418 -10,631.5%   
Profit after tax Rs m-4,00717 -23,567.6%  
Gross profit margin %13.219.4 68.0%  
Effective tax rate %32.451.6 62.9%   
Net profit margin %-55.80.4 -13,728.0%  
BALANCE SHEET DATA
Current assets Rs m14,3352,771 517.4%   
Current liabilities Rs m49,8091,931 2,579.0%   
Net working cap to sales %-494.020.1 -2,461.9%  
Current ratio x0.31.4 20.1%  
Inventory Days Days403125 322.6%  
Debtors Days Days17154 317.5%  
Net fixed assets Rs m55,4325,328 1,040.3%   
Share capital Rs m268114 234.2%   
"Free" reserves Rs m13,9354,177 333.6%   
Net worth Rs m14,7014,376 335.9%   
Long term debt Rs m9,4781,911 496.1%   
Total assets Rs m73,9888,428 877.9%  
Interest coverage x-0.41.1 -32.5%   
Debt to equity ratio x0.60.4 147.7%  
Sales to assets ratio x0.10.5 19.6%   
Return on assets %0.54.7 10.6%  
Return on equity %-27.30.4 -7,015.6%  
Return on capital %-6.46.6 -97.4%  
Exports to sales %25.90-   
Imports to sales %0.220.5 0.8%   
Exports (fob) Rs m1,860NA-   
Imports (cif) Rs m12858 1.4%   
Fx inflow Rs m1,8600-   
Fx outflow Rs m25858 2.9%   
Net fx Rs m1,835-858 -213.8%   
CASH FLOW
From Operations Rs m1,719469 366.6%  
From Investments Rs m-3,14829 -10,781.5%  
From Financial Activity Rs m1,426-464 -307.7%  
Net Cashflow Rs m-335 -9.9%  

Share Holding

Indian Promoters % 33.9 32.9 103.2%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 0.2 -  
FIIs % 9.9 0.6 1,706.9%  
ADR/GDR % 16.9 0.0 -  
Free float % 39.3 66.4 59.2%  
Shareholders   21,482 20,121 106.8%  
Pledged promoter(s) holding % 55.9 36.4 153.9%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare STERLING BIOTECH With:   STRIDES SHASUN LTD  AJANTA PHARMA  ALEMBIC LTD  DR. DATSONS LABS  CADILA HEALTHCARE  

Compare STERLING BIOTECH With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices Extend Losses; Capital Goods Sector Down 1.7%(11:30 am)

Indian share markets are presently trading on a negative note. Sectoral indices are trading in the red with stocks in the capital goods sector and metal sector witnessing maximum selling pressure.

Related Views on News

Galaxy Surfactants Ltd. (IPO)

Jan 27, 2018

Should you subscribe to the IPO of Galaxy Surfactants Ltd?

Tata Chem: Suspension of Haldia Operations Drag Bottomline Lower (Quarterly Results Update - Detailed)

Aug 17, 2017

Interruption at Haldia plant and fire at Lostock facility hits operations during the quarter.

Galaxy Surfactants Ltd. (IPO)

Jan 27, 2018

Should you subscribe to the IPO of Galaxy Surfactants Ltd?

Tata Chem: Suspension of Haldia Operations Drag Bottomline Lower (Quarterly Results Update - Detailed)

Aug 17, 2017

Interruption at Haldia plant and fire at Lostock facility hits operations during the quarter.

More Views on News

Most Popular

Here's What You Should Do in this Market Crash(The 5 Minute Wrapup)

Feb 6, 2018

The market correction has provided a golden opportunity to buy five high-quality safe stocks.

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

The Markets Want Your Money. Don't Give It to Them.(Smart Contrarian)

Feb 9, 2018

MFs are having a gala time taking money from over-eager investors and funneling it into equities. Smart investors, though, know better than to do that.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

When Small is Not Always Beautiful(Chart Of The Day)

Feb 6, 2018

Big companies enjoying tax deductions and exemptions have an edge over the small companies.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

STERLING BIOTECH SHARE PRICE


Feb 19, 2018 12:23 PM

TRACK STERLING BIOTECH

  • Track your investment in STERLING BIOTECH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON STERLING BIOTECH

STERLING BIOTECH - SHASUN PHARMA COMPARISON

COMPARE STERLING BIOTECH WITH

MARKET STATS